Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits
- 1 December 2002
- journal article
- research article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 21 (12) , 649-657
- https://doi.org/10.1191/0960327102ht311oa
Abstract
This study compares the chronic toxicity of two anthracyclines–daunorubicin and doxorubicin, commonly used for induction of anthracycline cardiomyopathy in the rabbit model. Such a comparative study has not been published until now. Both drugs were administered intravenously to male Chinchilla rabbits in doses at 3 mg/ kg (50 mg/m2) once weekly for 10 weeks. Selected biochemical, haematological and cardiovascular parameters and body weights were regularly monitored; additionally, a histological evaluation of heart, kidney and liver was performed at the end of the experiment. In the daunorubicin group, there were marked signs of the progressive development of heart failure, like the significant increases of the pre-ejection period/left ventricular ejection time index values (up to 134%)–and histological changes within the myocardium were also observed. On the other hand, the 10-week doxorubicin administration did not cause these changes that are typical for heart injury. Haematotoxicity, manifested particularly by aplastic anaemia, was apparent in both the experimental groups. Significant body weight loss (by 45.2%) and high premature mortality (100% versus 36.4%) reflected a greater general toxicity, especially nephrotoxicity of doxorubicin in comparison with daunorubicin. Further studies are necessary to find a possible explanation for these findings.Keywords
This publication has 26 references indexed in Scilit:
- Effects of water-soluble antioxidant from spinach, NAO, on doxorubicin-induced heart injuryHuman & Experimental Toxicology, 2001
- Cardiotoxicity of Chemotherapeutic AgentsDrug Safety, 2000
- Chronic Adriamycin Treatment Impairs Myocardial Interstitial Neuronal Release of Norepinephrine and EpinephrineJournal of Cardiovascular Pharmacology, 2000
- IGF-I in experimental daunorubicin-induced cardiomyopathy in rabbitsHuman & Experimental Toxicology, 1999
- Sarcoplasmic Reticulum Genes are Selectively Down-regulated in Cardiomyopathy Produced by Doxorubicin in RabbitsJournal of Molecular and Cellular Cardiology, 1998
- DexrazoxaneDrugs, 1998
- Animal models of anthracycline cardiotoxicity: Basic mechanisms and cardioprotective activityProgress in Pediatric Cardiology, 1997
- Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivative of indenoisochinoline: comparison with daunorubicin in rabbitsArchives of Toxicology, 1996
- Exacerbation of doxorubicin cardiotoxicity by digoxin administration in an experimental rabbit modelInternational Journal of Cancer, 1990
- Dose-response relationships of chronic adriamycin toxicity in rabbitsEuropean Journal of Cancer and Clinical Oncology, 1984